The AHK-Cu vs GHK-Cu comparison defines the copper peptide research landscape — two tripeptide-copper complexes that share a structural backbone and copper delivery function but differ by a single amino acid that changes their tissue affinity, research profile, and optimal applications. GHK-Cu (Gly-His-Lys:Cu²⁺) is a naturally occurring copper peptide with the broadest research base of any cosmetic peptide — published genomic studies show it modulates over 4,000 human genes related to collagen synthesis, wound healing, and anti-inflammation. AHK-Cu (Ala-His-Lys:Cu²⁺) is a synthetic analogue with the most direct published evidence for hair follicle stimulation specifically — the Pyo 2007 study documented dermal papilla cell proliferation and ex vivo hair follicle elongation at picomolar concentrations.

PSPeptides carries both: AHK-Cu vial and GHK-Cu vial, plus GHK-Cu Spray, GHK-Cu Serum, and GHK-Cu Tablets. For individual compound guides, see our AHK-Cu guide and GHK-Cu guide.

The One Amino Acid Difference That Changes Everything

GHK-Cu uses glycine at position 1: Gly-His-Lys:Cu²⁺. AHK-Cu substitutes alanine: Ala-His-Lys:Cu²⁺. Glycine is the smallest amino acid (hydrogen side chain); alanine adds a methyl group. This single substitution alters the peptide’s three-dimensional conformation, receptor binding affinity, and tissue-specific biological activity — demonstrating how even minimal structural changes in peptide chemistry can produce meaningfully different pharmacological profiles.

The histidine and lysine residues — shared by both peptides — are primarily responsible for copper(II) ion coordination. The imidazole nitrogen of histidine and the ε-amino group of lysine form coordinate bonds with the copper ion, creating the stable peptide-metal complex that both compounds share. The first-position amino acid (glycine or alanine) influences the overall peptide conformation and may affect how the copper complex interacts with cellular receptors and tissue surfaces, potentially explaining the tissue-specific differences in biological activity between the two variants.

The Pyo 2007 Study: AHK-Cu’s Foundational Evidence

The landmark evidence for AHK-Cu comes from Pyo et al., published in Archives of Pharmacal Research (2007). This study used two experimental systems to evaluate AHK-Cu’s hair follicle effects — making it the most directly follicle-focused study published for any copper peptide.

Dermal papilla cell (DPC) proliferation: The dermal papilla is the mesenchymal signaling center at the base of each hair follicle that produces the growth factors driving follicular cycling and hair shaft production. When DP cells lose their inductive capacity — as occurs in androgenetic alopecia — follicles miniaturize and eventually produce only vellus (fine, unpigmented) hairs. Pyo demonstrated that AHK-Cu increased DPC proliferation at picomolar to nanomolar concentrations — remarkably low concentrations suggesting high receptor-mediated potency rather than simple copper supplementation effects.

Hair follicle elongation: Using ex vivo human hair follicle organ culture — isolated follicles maintained outside the body — AHK-Cu treatment increased follicle length, consistent with anagen phase promotion. This model uses actual human follicles rather than cell cultures or animal models, providing direct evidence of effects on intact human follicular structures with their complete cellular architecture.

Apoptosis-related markers: AHK-Cu demonstrated shifts in apoptosis-related markers in dermal papilla cells — an elevated Bcl-2/Bax ratio and reduced levels of cleaved caspase-3 and PARP — though the reduction in apoptotic DPC counts did not reach statistical significance. The same Seoul National University research group had previously used identical DPC models to study minoxidil — placing AHK-Cu’s effects in the context of established hair biology methodology.

GHK-Cu’s Hair Evidence: Broader But Less Direct

GHK-Cu does not have a single landmark follicle-focused study equivalent to Pyo 2007. Instead, its hair growth evidence emerges from its broader genomic research profile. Published Connectivity Map studies by Pickart, Loren, and colleagues showed that GHK-Cu modulates genes directly relevant to hair biology including collagen III (follicular sheath structural protein), decorin (regulates TGF-β signaling involved in hair cycling), Wnt pathway components (critical for follicle morphogenesis and cycling), and anti-inflammatory genes (scalp inflammation contributes to hair loss). Additionally, GHK-Cu’s promotion of angiogenesis through multiple growth factor pathways supports perifollicular vascularization — though through broader gene expression modulation rather than the targeted DPC proliferation AHK-Cu demonstrates specifically.

The practical difference for researchers designing protocols: AHK-Cu has narrow but quantitatively deep follicle-specific evidence (one comprehensive study with multiple follicle-specific endpoints). GHK-Cu has broad but indirect hair evidence (thousands of modulated genes that include hair-relevant pathways among many others). For researchers who need to cite published evidence specifically documenting hair follicle effects, AHK-Cu’s Pyo 2007 data is more directly applicable — it provides quantitative data on DPC proliferation rates and follicle elongation measurements that can be directly referenced in research proposals, grant applications, and published methodology sections. The ex vivo human follicle organ culture model used in the Pyo study is particularly valuable because it demonstrates effects on intact human follicular structures rather than isolated cell populations — providing evidence that translates more directly to the integrated follicular biology that determines actual hair growth outcomes. For researchers designing protocols based on the broadest possible regenerative support for scalp tissue, GHK-Cu’s 4,000+ gene modulation profile provides more comprehensive coverage.

AHK-Cu vs GHK-Cu: Complete Comparison

When to Choose AHK-Cu

Choose AHK-Cu when the research question is specifically about hair follicle biology. The Pyo 2007 study provides the most direct published evidence for copper peptide effects on dermal papilla cell proliferation and ex vivo human hair follicle elongation. AHK-Cu at picomolar to nanomolar concentrations stimulated DPC proliferation and demonstrated shifts in apoptosis-related markers (Bcl-2/Bax, caspase-3/PARP) — remarkably potent effects at very low concentrations that suggest high receptor-mediated specificity rather than simple copper supplementation effects. The ex vivo organ culture model used intact human follicles rather than isolated cell populations, providing evidence that translates directly to integrated follicular biology. For hair-focused protocols where citing quantitative follicular data in research documentation matters, AHK-Cu is the more specifically validated and directly citable compound.

When to Choose GHK-Cu

Choose GHK-Cu when the research question extends beyond hair to include skin quality, wound healing, collagen synthesis, or comprehensive anti-aging. GHK-Cu’s published genomic data showing modulation of over 4,000 genes — including collagen I, III, elastin, decorin, MMPs, TIMPs, inflammatory cytokines, and antioxidant enzymes — makes it the broadest-spectrum regenerative peptide available. Its 1,016% year-over-year search growth reflects the explosion of interest in copper peptides for skin applications driven by social media and the cosmetic dermatology community. PSPeptides’ multiple GHK-Cu formats — spray, serum, vial, tablets — enable topical, systemic, and oral delivery for different research designs. See our hair growth guide and skin peptide guide.

When to Use Both

For maximum hair growth research support, combining AHK-Cu (direct follicular stimulation via DPC proliferation) with GHK-Cu (broader regenerative gene modulation supporting scalp tissue health) addresses hair biology from both the follicle-specific and tissue-environment perspectives. Their mechanisms do not fully overlap — AHK-Cu provides targeted follicular effects while GHK-Cu provides the extracellular matrix remodeling, anti-inflammatory, and antioxidant gene expression that supports the broader scalp environment within which follicles operate. PSPeptides carries both AHK-Cu and GHK-Cu for comparative and combination protocols. A practical dual copper peptide scalp protocol would use the ready-to-use GHK-Cu spray for broad regenerative coverage across the entire scalp surface, combined with reconstituted AHK-Cu applied topically to areas of specific concern where targeted follicular stimulation is the priority — for example, areas of visible thinning where targeted DPC stimulation is most urgently needed. The spray provides convenient daily whole-scalp coverage, while the targeted AHK-Cu application concentrates the follicle-specific compound where it has the highest potential impact. For researchers designing comprehensive multi-peptide hair protocols that extend beyond copper peptides, adding injectable or spray TB-500 for stem cell activation and BPC-157 for VEGF through the nitric oxide pathway creates a four-mechanism hair protocol. For hair protocols adding non-copper mechanisms, TB-500 promotes hair follicle stem cell activation and BPC-157 provides VEGF-mediated angiogenesis through a pathway distinct from AHK-Cu’s copper-mediated follicular effects.

The Copper Ion: More Than a Structural Component

Both AHK-Cu and GHK-Cu function as copper delivery vehicles — the tripeptide structure binds and transports the copper(II) ion to tissue sites where copper-dependent biological processes occur. Copper is an essential trace mineral required as a cofactor for lysyl oxidase (collagen and elastin cross-linking), superoxide dismutase (Cu/Zn-SOD antioxidant defense), cytochrome c oxidase (mitochondrial energy production), and tyrosinase (melanin synthesis). By delivering bioavailable copper to specific tissue sites, both peptides support the enzymatic processes that depend on adequate copper availability — processes that may be compromised in aging tissue where local copper distribution changes.

The peptide component adds biological signaling beyond simple copper delivery. Published research confirms that GHK-Cu’s gene expression modulation profile extends far beyond what copper ion delivery alone could produce — the tripeptide itself interacts with cellular receptors and signaling pathways that trigger transcriptomic changes affecting thousands of genes. Similarly, AHK-Cu’s picomolar-concentration effects on DPC proliferation suggest receptor-mediated signaling rather than simple copper supplementation — copper ions alone at picomolar concentrations would not produce measurable biological effects.

Evidence Depth Comparison

GHK-Cu’s evidence base is substantially broader and deeper than AHK-Cu’s. GHK-Cu has been studied for over 30 years since its initial identification by Pickart in 1973, with published research spanning wound healing (animal models showing accelerated wound closure and improved tissue strength), skin aging (collagen synthesis increased 70%+ in fibroblast cultures), gene expression (4,000+ genes modulated in Connectivity Map studies), anti-inflammation (cytokine suppression), antioxidant defense (SOD and catalase upregulation), and hair biology (follicular gene modulation). This breadth of evidence is unmatched by any other cosmetic peptide.

AHK-Cu’s evidence base centers on a single landmark study — the 2007 Pyo et al. publication in Archives of Pharmacal Research — that provides high-quality, specific data on follicular effects but lacks the multi-study, multi-institution, multi-decade validation that supports GHK-Cu. For hair-specific endpoints, AHK-Cu’s evidence is more directly relevant. For everything else, GHK-Cu’s evidence is vastly more comprehensive. Researchers should weight their compound selection based on which evidence profile better matches their specific research question.

Formulation and Delivery Considerations

PSPeptides offers GHK-Cu in five formats — spray, serum, vial, tablets, and in blend products — reflecting its broad research applicability. AHK-Cu is available as a lyophilized vial for reconstitution and custom formulation. Both copper peptides are stable at pH 5.0-6.5 (typical skin surface pH), and both have molecular weights (~400 Da) supporting transdermal penetration through the scalp’s relatively thin stratum corneum. For topical hair research, AHK-Cu can be reconstituted and applied topically alongside the ready-to-use GHK-Cu spray for a dual copper peptide scalp protocol. For reconstitution guidance, see our reconstitution guide. For storage, see our peptide storage guide.

The Hair Growth Cycle: Where Copper Peptides Intervene

Understanding the hair growth cycle helps explain where AHK-Cu and GHK-Cu each provide their greatest contribution. The hair cycle consists of three phases: anagen (active growth, lasting 2-7 years), catagen (regression, lasting 2-3 weeks), and telogen (resting, lasting 2-4 months). Hair loss conditions typically involve shortened anagen phase duration (less time growing), premature catagen entry (earlier regression), and follicle miniaturization (progressive shrinking of the hair follicle structure that produces thinner, shorter hairs with each cycle).

AHK-Cu’s documented effects map primarily to the anagen phase — DPC proliferation supports the signaling center that drives anagen, follicle elongation reflects extended time in the active growth phase, and anti-apoptotic effects protect the follicular cells whose survival is necessary for continued growth. AHK-Cu is essentially an anagen-promoting peptide that helps maintain follicles in their active growth phase.

GHK-Cu’s effects span multiple phases — collagen and extracellular matrix modulation support the structural environment in which follicles operate across all cycle phases, anti-inflammatory gene modulation reduces the scalp inflammation that can trigger premature catagen entry, and Wnt pathway modulation may influence the anagen-catagen transition signaling. GHK-Cu provides a broader cycle-wide support rather than targeting a single phase specifically. For researchers studying the hair cycle alongside other follicle-stimulating approaches, our hair growth guide covers TB-500 (stem cell activation), BPC-157 (VEGF through a different pathway), and other compounds.

The 1,016% year-over-year growth in GHK-Cu search volume reflects not only hair research interest but the broader social media-driven awareness of copper peptides for skin anti-aging — driven by viral content on TikTok and Instagram showcasing copper peptide serum results. This search growth creates a massive SEO opportunity for content covering both copper peptide variants. Our GHK-Cu research guide, topical serum guide, and Matrixyl vs GHK-Cu comparison provide comprehensive coverage of the copper peptide landscape.

Both copper peptide variants require proper reconstitution and storage to maintain the integrity of the copper-peptide coordination bond. Exposure to strong chelating agents, extreme pH conditions, or prolonged light exposure can disrupt the copper ion coordination, reducing biological activity and compromising research outcomes in laboratory applications.

Frequently Asked Questions

What is the difference between AHK-Cu and GHK-Cu?

One amino acid substitution at position 1: AHK-Cu uses alanine, GHK-Cu uses glycine. This changes their tissue affinity and research profiles. AHK-Cu has the most direct published evidence for hair follicle effects — DPC proliferation and follicle elongation at picomolar concentrations (Pyo 2007). GHK-Cu has vastly broader evidence spanning wound healing, collagen synthesis (+70%), anti-inflammation, antioxidant defense, and modulation of 4,000+ genes across multiple tissue types. For hair-focused research, AHK-Cu is more specifically validated. For comprehensive tissue regeneration, GHK-Cu has deeper and wider documentation.

Which copper peptide is better for hair growth?

AHK-Cu has the most direct hair follicle data from the Pyo 2007 study using human dermal papilla cells and ex vivo follicle organ culture. GHK-Cu has broader regenerative effects including hair-relevant gene modulation alongside its comprehensive skin and tissue programs. Using both provides complementary hair support — AHK-Cu for targeted follicular stimulation at the DPC level, GHK-Cu for optimizing the broader scalp tissue environment. PSPeptides carries both for comparative and combination protocols.

Is GHK-Cu naturally occurring?

Yes — GHK-Cu is found in human plasma at approximately 200 ng/mL in young adults, declining to ~80 ng/mL by age 60. AHK-Cu is purely synthetic with no known endogenous presence. The age-related decline of GHK-Cu correlates with visible signs of skin aging and reduced tissue repair capacity.

Can I apply copper peptides topically?

Yes. Both AHK-Cu and GHK-Cu have small molecular weights (~400 Da) that support transdermal penetration, particularly on the scalp. PSPeptides offers ready-to-use topical formats: GHK-Cu Spray and GHK-Cu Serum for direct skin/scalp application.

All PSPeptides products are sold exclusively for research and laboratory use.